| Literature DB >> 25001974 |
Angel Lanas1, Carlos Sostres1.
Abstract
A new study suggests that co-prescription of low-dose aspirin and PPIs increases the incidence of small-bowel mucosal breaks. Should we be concerned about the potential negative interactions of these drugs? Or is the balance of evidence still substantially tipped towards the need for PPIs to protect against aspirin-induced upper gastrointestinal damage?Entities:
Mesh：
Substances：
Year: 2014 PMID： 25001974 DOI： 10.1038/nrgastro.2014.120
Source DB: PubMed Journal: Nat Rev Gastroenterol Hepatol ISSN： 1759-5045 Impact factor: 46.802